数据链接：
官方服务：
资源简介：
Cost per day for ARV medications a.
应用场景：
创建时间：
2018-08-10
相关数据集
Supplementary materials: Cost–effectiveness and cost–benefit analysis of oliceridine in the treatment of acute pain
These are peer-reviewed supplementary tables for the article ' Cost–effectiveness and cost-benefit analysis of oliceridine in the treatment of acute pain ' published in the Jo
DataCite Commons2026-04-29 更新180
Input parameters for the base-case analysis.
Background Expanding the indication of already approved immuno-oncology drugs presents treatment opportunities for patients but also strains healthcare systems. Cost-based pricing models are discussed
NIAID Data Ecosystem50
Cost-effectiveness analysis for avelumab first-line maintenance treatment of advanced urothelial carcinoma in Scotland - supplementary material
Figure S1. Model schematic.Curves provided in this image are hypothetical to illustrate how health state occupancy is determined. OS: overall survival; PD: progressed disease; PF: progression f
Taylor & Francis Group2024-05-15 更新30
Cost-effectiveness of cardiovascular medicines for primary prevention of Ischemic Heart Disease.
Cost-effectiveness of cardiovascular medicines for primary prevention of Ischemic Heart Disease.
NIAID Data Ecosystem50
Using Penalized Synthetic Controls on Truncated data: A Case Study on Effect of Marijuana Legalization on Direct Payments to Physicians by Opioid Manufacturers
Amid increasing awareness regarding opioid addiction, medical marijuana has emerged as a substitute to opioids for pain management. Concurrently, opioid manufacturers are putting significant research
Taylor & Francis Group2024-11-19 更新40
